Searched for
RABIES DRUG
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- Centre set to tighten oversight of pharma packaging materialsIndia is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Fake life-saving medicine racket busted in Delhi: Here's how they repackaged and sold drugs across several statesDelhi Police crime branch busted an interstate counterfeit medicine racket, arresting four individuals. The network allegedly sourced gover...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Abhayrab rabies vaccine: IIL says counterfeit batch no longer availableIndian Immunologicals Limited clarifies a packaging anomaly in one batch of its anti-rabies vaccine, Abhayrab. The company states that coun...
- COVID-19: 16 companies get funds for R&D workThe department of biotechnology has granted funds to 16 companies for developing drugs, vaccines and devices to fight the Covid-19 pandemic...
- Bharat Biotech's subsidiary Chiron Behring launches anti-rabies vaccine“In our ongoing commitment to address the supply shortages of rabies vaccine, we are making additional investments to increase production c...
- Zydus Cadila receives DCGI nod to market rabies drug in IndiaZydus said it currently also manufactures and markets the rabies vaccine — VaxiRab.
- China launches nationwide action after faulty rabies vaccineHealth institutions and disease control centres across China are providing consultation services for people who received rabies vaccines ma...
- Recalling defective vaccines will deal heavy blow to China's drug exports: expertsChina initiated protocols on Tuesday to recall fake rabies vaccines sold in other countries and regions amid the recent vaccine scandal.
- Serum eyes Rs 10,000 crore revenues by 2022, unveils new vaccinesThe company is also developing vaccine and drug for dengue fever. It has commenced first phase of trials in Singapore and hopes to launch v...
- NPPA slashes prices of medicines for TB, cancer, hepatitis B by up to 20%The move is expected to slash prices of some of these drugs, like Hepatitis B immunoglobulin, by as much as 20%, a senior government told E...
- Rabishield: First fast-acting anti-rabies drug set for India launchRMAb has been developed by Pune-based Serum Institute of India (SII) and US-based Mass Biologics of the University of Massachusetts Medical...
- Government withdraws customs exemption on 74 drugsAlso drugs used for treating menopause, glaucoma, anogenital warts, poisoning by a chemical, growth failure in children would also attract ...
- Novartis to buy Aventis stake in rabies vaccine JV for $22 millionAventis Pharma, the Indian arm of Sanofi Aventis, is exiting its joint venture Chiron Behring Vaccines by selling its 49% to the other part...
- HC stays Aventis' anti-rabies drug distributionThe Bombay High Court has restrained Aventis Pharma from distributing anti-rabies vaccine Verorab, and allowed the arbitration application ...
- No shortage of rabies vaccine: Novartis IndiaNovartis India said there was no shortage of rabies vaccine in the country, despite manufacturing constraints at Ankaleswar plant of Chiron...
- Novartis-Aventis row leads to shortage of anti-rabies vaccineBeware of Dogs! There is a shortage of anti-rabies vaccine in the country, thanks to a dispute between Novartis and Sanofi Aventis, which t...
- Cadila, WHO to develop rabies drugPharma firm Cadila Healthcare said it has entered into an agreement with the World Health Organisation to develop drug for the treatment of...
Load More
